Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.

XSEC:301617 Stock Report

Market Cap: CN¥5.0b

Shandong Boyuan Pharmaceutical & Chemical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Guoqing Yu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership26.5%
Management average tenure1.4yrs
Board average tenureno data

Recent management updates

Recent updates


CEO

Guoqing Yu (55 yo)

no data
Tenure

Mr. Guoqing Yu is Vice Chairman & GM of Shandong Boyuan Pharmaceutical & Chemical Co. Ltd.


Leadership Team

NamePositionTenureCompensationOwnership
Guoqing Yu
Vice Chairman & GMno datano data26.51%
CN¥ 1.3b
Teng Sun
Financial Director3.8yrsno datano data
Enxun Wang
Deputy GM & Directorno datano data0.49%
CN¥ 24.1m
Jie Zhang
Deputy General Manager1.4yrsno datano data
Tong Liu
Deputy General Manager1.4yrsno datano data
1.4yrs
Average Tenure
43yo
Average Age

Experienced Management: 301617's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 21:47
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.